Chi Van Dang MD PhD
Director, Abramson Cancer Center; Professor, Medicine, Perelman School of Medicine
Join to view full profile
3400 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-615-5858
Dr. Dang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1985 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1983 - 1985- Johns Hopkins UniversityInternship, Internal Medicine, 1982 - 1983
- Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 2012 - 2021
MD State Medical License 1982 - 2012
Awards, Honors, & Recognition
- Member, Institute of Medicine National Academy of Sciences
- Fellow American Academy of Arts & Sciences
Publications & Presentations
PubMed
- Do autoantibodies shape cancer immunosurveillance?Paul Bastard, Tyler Hulett, Karl Smith-Byrne, Nils Landegren, Trine H Mogensen
Cell. 2026-07-23 - 1 citationsWnt signaling and the tumor microenvironment: implications for cancer progression and therapeutics.Ashok Bharathy Mariappan Ragupathi, Chi V Dang, Daniel J Zabransky
Oncogene. 2026-05-01 - Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.Howard L Li, Soren Charmsaz, Benjamin J Reisman, Franshisca Hayek, Madelena Brancati
Journal for Immunotherapy of Cancer. 2026-04-21
Press Mentions
It Matters What Time of Day You Get Cancer Treatment, Study SuggestsDecember 18th, 2025- Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and SignalingFebruary 8th, 2022
- Potential Tumor Vulnerability May Be Exploited to Improve Treatment of NeuroblastomaFebruary 7th, 2022
Grant Support
- Defining metabolic adaptations within the PDAC "arid" tumor microenvironmentJOHNS HOPKINS UNIVERSITY2021–2026
- Defining the Role of the Cancer Circadian Clock in Tumor Immunity and TumorigenesisJOHNS HOPKINS UNIVERSITY1990–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
